Precision Biologics, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
Precision Biologics, Inc. is a Bethesda, Maryland-based biotechnology company focused on cancer research. It develops monoclonal antibodies with multiple mechanisms aimed at countering tumor growth and pursues products for both therapy and diagnosis in oncology. Two antibody programs, NEO-102 and NEO-201, are in clinical trials for several solid tumors. The company aims to improve cancer patient outcomes through its therapeutic and diagnostic offerings. As a small biotechnology firm, it maintains an active research program, including the disclosure of a new AML CAR-NK target at AACR 2026.